BRIEF-SIFI s.p.a., Knight Therapeutics in canadian license agreement for NETILDEX(tm)
Aug 2 (Reuters) - Knight Therapeutics Inc
* SIFI s.p.a. and Knight Therapeutics announce canadian license agreement for NETILDEX(tm)
* Knight will also handle all ongoing regulatory and commercial activities for netildex(tm) in canada. Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.